Siloam International Hospitals (SILO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Siloam International Hospitals (SILO) has a cash flow conversion efficiency ratio of 0.042x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp388.57 Billion ≈ $22.77 Million USD) by net assets (Rp9.25 Trillion ≈ $541.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Siloam International Hospitals net asset quality index to measure how much of total assets are equity-financed.
Siloam International Hospitals - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how Siloam International Hospitals's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Siloam International Hospitals (SILO) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Siloam International Hospitals Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Siloam International Hospitals ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Grupo Lamosa S.A.B. de C.V
MX:LAMOSA
|
0.031x |
|
Hyundai Doosan Infracore Co Ltd
KO:042670
|
0.072x |
|
Syngene International Limited
NSE:SYNGENE
|
-0.010x |
|
Austevoll Seafood ASA
OL:AUSS
|
0.052x |
|
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
|
-1.210x |
|
RLX Technology Inc
NYSE:RLX
|
0.022x |
|
Beijing Yuanliu Hongyuan Electronic Technology Co Ltd
SHG:603267
|
-0.030x |
|
Beijing Highlander Digital Technology Co Ltd
SHE:300065
|
-0.029x |
Annual Cash Flow Conversion Efficiency for Siloam International Hospitals (2010–2024)
The table below shows the annual cash flow conversion efficiency of Siloam International Hospitals from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see SILO market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp8.75 Trillion ≈ $512.81 Million |
Rp2.33 Trillion ≈ $136.54 Million |
0.266x | +2.11% |
| 2023-12-31 | Rp8.05 Trillion ≈ $471.56 Million |
Rp2.10 Trillion ≈ $122.96 Million |
0.261x | +22.99% |
| 2022-12-31 | Rp7.05 Trillion ≈ $413.19 Million |
Rp1.50 Trillion ≈ $87.60 Million |
0.212x | -31.97% |
| 2021-12-31 | Rp6.52 Trillion ≈ $382.28 Million |
Rp2.03 Trillion ≈ $119.13 Million |
0.312x | +40.32% |
| 2020-12-31 | Rp6.02 Trillion ≈ $352.65 Million |
Rp1.34 Trillion ≈ $78.32 Million |
0.222x | +104.11% |
| 2019-12-31 | Rp5.99 Trillion ≈ $350.85 Million |
Rp651.51 Billion ≈ $38.18 Million |
0.109x | +237.51% |
| 2018-12-31 | Rp6.32 Trillion ≈ $370.13 Million |
Rp203.64 Billion ≈ $11.93 Million |
0.032x | -9.85% |
| 2017-12-31 | Rp6.31 Trillion ≈ $369.95 Million |
Rp225.78 Billion ≈ $13.23 Million |
0.036x | -53.35% |
| 2016-12-31 | Rp3.13 Trillion ≈ $183.35 Million |
Rp239.87 Billion ≈ $14.06 Million |
0.077x | -47.72% |
| 2015-12-31 | Rp1.74 Trillion ≈ $101.95 Million |
Rp255.15 Billion ≈ $14.95 Million |
0.147x | -14.52% |
| 2014-12-31 | Rp1.65 Trillion ≈ $96.90 Million |
Rp283.68 Billion ≈ $16.62 Million |
0.172x | +48.41% |
| 2013-12-31 | Rp1.64 Trillion ≈ $96.04 Million |
Rp189.45 Billion ≈ $11.10 Million |
0.116x | -86.07% |
| 2012-12-31 | Rp244.64 Billion ≈ $14.33 Million |
Rp203.01 Billion ≈ $11.90 Million |
0.830x | +177.97% |
| 2011-12-31 | Rp178.96 Billion ≈ $10.49 Million |
Rp53.43 Billion ≈ $3.13 Million |
0.299x | -84.41% |
| 2010-12-31 | Rp137.58 Billion ≈ $8.06 Million |
Rp263.40 Billion ≈ $15.43 Million |
1.915x | -- |
About Siloam International Hospitals
PT Siloam International Hospitals Tbk operates hospitals and clinics in Indonesia. The company offers general, pre-marital, and lite checkups; male and female screenings; heart, kidney, and cancer screenings; visa application and preemployment screenings; and vaccine and genomic testing services. It also provides diagnostic services, including laboratory and radiology checks; home services; COVID… Read more